Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management

Current Rheumatology Reports

Volumn 16, Issue 12, 2014, Pages

  Bailey, Elizabeth E ^a   Fiorentino, David F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinically amyopathic; Dermatomyositis; Hypomyopathic; Premyopathic

Indexed keywords

AUTOANTIBODY; CADM 140 ANTIBODY; MDA5 ANTIBODY; UNCLASSIFIED DRUG;

CLINICALLY AMYOPATHIC DERMATOMYOSITIS; DERMATOMYOSITIS; ERYTHEMA; HAND INJURY; HUMAN; HYPERKERATOSIS; INTERSTITIAL LUNG DISEASE; MYOSITIS; NASOPHARYNX CARCINOMA; NON SMALL CELL LUNG CANCER; PAPULE; POIKILODERMA; RASH; REVIEW; SKIN CALCIFICATION; SKIN PRURITUS; SYSTEMIC THERAPY; TELANGIECTASIA; DISEASE COURSE; PATHOLOGY; SKIN;

DERMATOMYOSITIS; DISEASE PROGRESSION; HUMANS; SKIN;

EID: 84920281343     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-014-0465-0     Document Type: Review

References (28)

1. Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146:26–30.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292(344–347):403–7.
3. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20:387–408.
4. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54:597–613.
5. Ghazi E, Sontheimer RD, Werth VP. The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol. 2013;31:128–34.
6. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626–36.
7. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis): presentation of six new cases and review of the literature. J Am Acad Dermatol. 1991;24:959–66.
8. Euwer RL, Sontheimer RD. Dermatologic aspects of myositis. Curr Opin Rheumatol. 1994;6:583–9.
9. El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46:560–5.
10. Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol. 2009;28:979–84.
11. Gitiaux C, Kostallari E, Lafuste P, et al. Whole microvascular unit deletions in dermatomyositis. Ann Rheum Dis. 2013;72:445–52.
12. Stonecipher MR, Jorizzo JL, Monu J, Walker F, Sutej PG. Dermatomyositis with normal muscle enzyme concentrations: a single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound. Arch Dermatol. 1994;130:1294–9.
13. Lam WWM, Chan H, Chan YL, et al. MR imaging in amyopathic dermatomyositis. Acta Radiol. 1999;40:69.
14. Park JH, Olsen NJ, King L, et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum. 1995;38:68–77.
15. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571–6.
16. Nakashima R, Imura Y, Kobayashi S, et al. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology. 2010;49:433–40.
17. Hoshino K, Muro Y, Sugiura K, et al. Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology. 2010;49:1726–33.
18. Koga T, Fujikawa K, Horai Y, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology. 2012;51:1278–84.
19. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE. 2013;8:e60442.
20. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis, and polymyositis. Eur Respir J. 2003;22:245–50.
21. Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis, and amyopathic dermatomyositis. Rheumatology. 2005;44:1282–6.
22. Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest. 2009;136:1341–7.
23. Yamasaki Y, Yamada H, Ohkubo M, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38:1636–43.
24. Ye S, Chen X, Lu X, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26:1647–54.
25. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol. 2001;144:825–31.
26. Azuma K, Hidehiro Y, Ohkubo M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis, and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011;21:178–83.
27. Fung WKJ, Chan HLH, Lam WMW. Amyopathic dermatomyositis in Hong Kong – association with nasopharyngeal carcinoma. Int J Dermatol. 1998;37:659–63.
28. Chen Z, Cao M, Plana MN, et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res. 2013;65:1316–24.